Nucleic Acid Isolation and Purification Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

Nucleic Acid Isolation and Purification Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028


Market Overview:

The global nucleic acid isolation and purification market size reached US$ 4.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 8.1 Billion by 2028, exhibiting a growth rate (CAGR) of 8.5% during 2023-2028.

Nucleic acid isolation and purification are routine procedures in molecular biology and forensic analysis. They are used for separating deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) from proteins, membranes, and other cellular materials through reagent-based and column-based techniques. Hair, blood, bones, sperm, saliva, nails, and urine are some of the commonly used sources for nucleic acid isolation and purification. They assist clinicians in processing the samples in minimum time, diagnosing patients with genetic mutations, determining the high risk for cancer, developing new therapeutics, and enhancing the effectiveness of drugs. As a result, these techniques are extensively employed in various verticals, including bioscience research, gene-splicing, molecular diagnostics, pharmaceuticals, and forensics.

Nucleic Acid Isolation and Purification Market Trends:
The increasing employment of the procedure in pharmaceutical and biotechnological industries across the globe represents one of the key factors driving the market growth. Nucleic acid isolation and purification are used to identify microorganisms and genetic predispositions, detect different mutations, and determine their role in antibiotics. In line with this, the increasing prevalence of infectious diseases, genetic disorders, and chronic conditions, such as cancer, are favoring the market growth. Apart from this, the introduction of magnetic bead-based extraction kits used for liquid handling platforms that are capable of extracting the highest purity nucleic acids from tissue, blood, and plant materials is providing an impetus to the market growth. Furthermore, the rising awareness about genomic diagnostics among patients and the increasing efficiency of genomics sequencing in diagnosing diseases is acting as another growth-inducing factor. Additionally, the widespread utilization of DNA and RNA isolation for screening and detecting pathogens and microorganisms in routine samples and the rapid adoption of polymerase chain reaction (PCR) techniques to detect genetic abnormalities are supporting the market growth. Other factors, including the significant improvements in the healthcare infrastructure and extensive research and development (R&D) activities, are anticipated to drive the market toward growth.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global nucleic acid isolation and purification market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, type, method and end user.

Breakup by Product:

Kits and Reagents
Instruments

Breakup by Type:

Plasmid DNA Isolation and Purification
Total RNA Isolation and Purification
Circulating Nucleic Acid Isolation and Purification
Genomic DNA Isolation and Purification
Messenger RNA Isolation and Purification
microRNA Isolation and Purification
PCR Cleanup
Others

Breakup by Method:

Column-Based Isolation and Purification
Magnetic Bead-Based Isolation and Purification
Reagent-Based Isolation and Purification
Others

Breakup by End User:

Hospitals and Diagnostic Centers
Academic and Government Research Institutes
Pharmaceutical and Biotechnology Companies
Contract Research Organizations
Others

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abcam plc, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Illumina Inc., Macherey-Nagel Gmbh & Co. Kg, New England Biolabs, Norgen Biotek Corp., Omega Bio-Tek Inc., Promega Corporation, Qiagen, Roche Molecular Systems Inc. (F. Hoffmann-La Roche AG), Takara Bio Inc. (Takara Holdings Inc.) and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:
How has the global nucleic acid isolation and purification market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global nucleic acid isolation and purification market?
What are the key regional markets?
What is the breakup of the market based on the product?
What is the breakup of the market based on the type?
What is the breakup of the market based on the method?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global nucleic acid isolation and purification market and who are the key players?
What is the degree of competition in the industry?


1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Nucleic Acid Isolation and Purification Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Kits and Reagents
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Instruments
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Type
7.1 Plasmid DNA Isolation and Purification
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Total RNA Isolation and Purification
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Circulating Nucleic Acid Isolation and Purification
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Genomic DNA Isolation and Purification
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Messenger RNA Isolation and Purification
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 microRNA Isolation and Purification
7.6.1 Market Trends
7.6.2 Market Forecast
7.7 PCR Cleanup
7.7.1 Market Trends
7.7.2 Market Forecast
7.8 Others
7.8.1 Market Trends
7.8.2 Market Forecast
8 Market Breakup by Method
8.1 Column-Based Isolation and Purification
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Magnetic Bead-Based Isolation and Purification
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Reagent-Based Isolation and Purification
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by End User
9.1 Hospitals and Diagnostic Centers
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Academic and Government Research Institutes
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Pharmaceutical and Biotechnology Companies
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Contract Research Organizations
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Others
9.5.1 Market Trends
9.5.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Abcam plc
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Agilent Technologies Inc.
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 Bio-Rad Laboratories Inc.
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 Illumina Inc.
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 Macherey-Nagel Gmbh & Co. Kg
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.6 New England Biolabs
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.7 Norgen Biotek Corp.
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.8 Omega Bio-Tek Inc.
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.9 Promega Corporation
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.10 Qiagen
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11 Roche Molecular Systems Inc. (F. Hoffmann-La Roche AG)
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.12 Takara Bio Inc. (Takara Holdings Inc.)
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.12.3 Financials
15.3.13 Thermo Fisher Scientific Inc.
15.3.13.1 Company Overview
15.3.13.2 Product Portfolio
15.3.13.3 Financials
15.3.13.4 SWOT Analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings